Health · 60 views
Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds
In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana—THC and CBD—had significantly less…
AI Summary
Researchers have conducted a clinical trial involving patients with dementia and agitation, a condition often seen in those nearing hospice eligibility. The trial involved administering a medical formulation containing THC and CBD, two active ingredients found in marijuana, to patients with agitation and dementia. The results showed that patients receiving this formulation experienced significantly less agitation compared to those who received a placebo.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Once-daily oral icotrokinra outperforms placebo in ulcerative colitisContinue reading
- Reprogramming tumor microenvironment could improve prospects for treatment of pancreatic cancerContinue reading
- Tegoprubart preserves kidney function better than tacrolimus in first-time transplant patients, trial suggestsContinue reading
- Melanoma vaccine reduces death or cancer recurrence by 42%Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow